| Literature DB >> 31970914 |
Motoki Endo1,2, Yosuke Inoue2, Keisuke Kuwahara2,3, Chihiro Nishiura4, Ai Hori5, Takayuki Ogasawara6, Miwa Yamaguchi2, Tohru Nakagawa7, Toru Honda7, Shuichiro Yamamoto7, Hiroko Okazaki8, Teppei Imai9, Akiko Nishihara10, Toshiaki Miyamoto11, Naoko Sasaki6, Akihiko Uehara12, Makoto Yamamoto13, Taizo Murakami14, Makiko Shimizu15, Masafumi Eguchi16, Takeshi Kochi16, Satsue Nagahama17, Kentaro Tomita18, Naoki Kunugita19, Takeshi Tanigawa1, Maki Konishi2, Akiko Nanri2,20, Isamu Kabe21, Tetsuya Mizoue2, Seitaro Dohi8.
Abstract
OBJECTIVE: In contrast to the association between excess weight and sickness absence (SA), the association in relation to underweight has been under-researched. This study aimed to examine the effects of BMI at both extremes of its distribution on SA.Entities:
Year: 2020 PMID: 31970914 PMCID: PMC7004170 DOI: 10.1002/oby.22703
Source DB: PubMed Journal: Obesity (Silver Spring) ISSN: 1930-7381 Impact factor: 5.002
Figure 1Participants in the Japan Epidemiology Collaboration on Occupational Health (2012‐2017).
Baseline characteristics of study participants in the Japan Epidemiology Collaboration on Occupational Health (2011)
| All participants | Baseline BMI categories | ||||
|---|---|---|---|---|---|
| < 18.5 | 18.5‐24.9 | 25.0‐29.9 | ≥ 30.0 | ||
|
| ( | ( | ( | ( | ( |
|
| 41.8 (10.3) | 37.2 (11.2) | 41.5 (10.5) | 43.5 (9.5) | 40.7 (9.4) |
|
| 25,213 (38.1) | 1,041 (45.2) | 16,623 (37.0) | 6,192 (39.0) | 1,357 (43.6) |
|
| 12,393 (18.7) | 144 (6.3) | 6,142 (13.7) | 4,657 (29.4) | 1,450 (46.6) |
|
| 9,353 (14.1) | 363 (15.8) | 5,452 (12.1) | 2,577 (16.2) | 961 (30.9) |
|
| 28,488 (43.1) | 282 (12.2) | 16,282 (36.3) | 9,804 (61.8) | 2,120 (68.1) |
|
| ( | ( | ( | ( | ( |
|
| 40.3 (9.7) | 38.0 (9.5) | 40.2 (9.7) | 42.7 (9.5) | 42.6 (8.7) |
|
| 1,297 (11.2) | 195 (10.9) | 885 (10.9) | 146 (11.4) | 71 (16.9) |
|
| 1,044 (9.0) | 60 (3.3) | 566 (7.0) | 257 (20.1) | 161 (38.3) |
|
| 1,523 (13.1) | 237 (13.2) | 993 (12.3) | 188 (14.7) | 105 (25.0) |
|
| 2,474 (21.3) | 162 (9.0) | 1,525 (18.8) | 559 (43.7) | 228 (54.3) |
Participants who took LTSA in Japan Epidemiology Collaboration on Occupational Health Study, stratified by ICD‐10 (those with at least 15 cases reported)
| ICD | Description | Cases |
|---|---|---|
|
| ||
|
| Depressive episode | 500 |
|
| Reaction to severe stress and adjustment disorders | 161 |
|
| Other anxiety disorders | 46 |
|
| Somatoform disorders | 23 |
|
| Other neurotic disorders | 20 |
|
| Schizophrenia | 18 |
|
| Bipolar affective disorder | 17 |
| Others | 67 | |
|
| ||
|
| Neoplasms | 313 |
|
| Diseases of the musculoskeletal system and connective tissue | 181 |
|
| Diseases of the circulatory system | 159 |
|
| Diseases of the nervous system | 73 |
|
| Pregnancy, childbirth, and the puerperium | 59 |
|
| Diseases of the digestive system | 58 |
|
| Diseases of the eye and adnexa | 32 |
|
| Endocrine, nutritional, and metabolic diseases | 25 |
|
| Diseases of the respiratory system | 20 |
|
| Diseases of the genitourinary system | 20 |
|
| Certain infectious and parasitic diseases | 19 |
|
| Diseases of the skin and subcutaneous tissue | 15 |
|
| Symptoms, signs, and abnormal clinical and laboratory findings not elsewhere classified | 15 |
| Others | 16 | |
|
| ||
|
| Fracture of lower leg, including ankle | 48 |
|
| Fracture of foot, except ankle | 16 |
|
| Fracture of shoulder and upper arm | 15 |
|
| Injury of muscle and tendon at lower leg level | 15 |
| Others | 111 | |
One individual did not provide information on cause of LTSA.
Adjusted HR and 95% CI for medically certified LTSA shown by baseline BMI categories among Japanese aged 20 to 59 years old (2012‐2017)
| Baseline BMI categories |
|
| ||||
|---|---|---|---|---|---|---|
| < 18.5 | 18.5‐24.9 | 25.0‐29.9 | ≥ 30.0 | |||
|
| ( | ( | ( | ( | ||
|
| 78 | 1,024 | 455 | 129 | ||
|
| 10,059 | 196,849 | 68,862 | 13,663 | ||
|
| 1.56 (1.23‐1.96) | ref. | 1.22 (1.09‐1.36) | 1.81 (1.50‐2.17) | < 0.001 | < 0.001 |
|
| 1.63 (1.29‐2.05) | ref. | 1.11 (0.99‐1.24) | 1.47 (1.21‐1.78) | 0.08 | < 0.001 |
|
| ( | ( | ( | ( | ||
|
| 49 | 255 | 58 | 15 | ||
|
| 7,468 | 34,127 | 5,283 | 1,773 | ||
|
| 0.86 (0.63‐1.16) | ref. | 1.54 (1.16‐2.05) | 1.20 (0.71‐2.02) | 0.01 | 0.79 |
|
| 0.89 (0.66‐1.22) | ref. | 1.31 (0.97‐1.76) | 0.86 (0.50‐1.49) | 0.31 | 0.41 |
Models adjusted for age, sex, and smoking status at baseline (Model 1), baseline hypertension, diabetes, and dyslipidemia (Model 2).
Cause‐specific analyses for medically certified LTSA shown by baseline BMI categories among Japanese males aged 20 to 59 years old (2012‐2017)
| Baseline BMI categories |
|
| ||||
|---|---|---|---|---|---|---|
| < 18.5 | 18.5‐24.9 | 25.0‐29.9 | ≥ 30.0 | |||
|
| 10,059 | 196,849 | 68,862 | 13,663 | ||
|
| ||||||
|
| 44 | 453 | 188 | 58 | ||
|
| 1.70 (1.25‐2.32) | ref. | 1.23 (1.04‐1.46) | 1.75 (1.33‐2.30) | 0.01 | < 0.001 |
|
| 1.79 (1.31‐2.45) | ref. | 1.13 (0.95‐1.35) | 1.51 (1.13‐2.01) | 0.21 | < 0.001 |
|
| ||||||
|
| 29 | 463 | 225 | 63 | ||
|
| 1.51 (1.04‐2.21) | ref. | 1.24 (1.06‐1.46) | 2.04 (1.57‐2.66) | < 0.001 | < 0.001 |
|
| 1.58 (1.08‐2.31) | ref. | 1.11 (0.94‐1.31) | 1.56 (1.18‐2.07) | 0.13 | < 0.001 |
|
| ||||||
|
| 5 | 155 | 73 | 11 | ||
|
| 0.83 (0.34‐2.04) | ref. | 1.18 (0.89‐1.56) | 1.15 (0.62‐2.13) | 0.25 | 0.72 |
|
| 0.83 (0.34‐2.03) | ref. | 1.15 (0.86‐1.53) | 1.05 (0.56‐1.98) | 0.41 | 0.63 |
|
| ||||||
|
| 2 | 51 | 35 | 10 | ||
|
| 1.00 (0.24‐4.10) | ref. | 1.68 (1.09‐2.58) | 3.03 (1.53‐6.00) | 0.002 | 0.47 |
|
| 1.23 (0.30‐5.12) | ref. | 1.28 (0.82‐2.00) | 1.71 (0.83‐3.53) | 0.23 | 0.53 |
|
| ||||||
|
| 6 | 90 | 35 | 11 | ||
|
| 1.53 (0.67‐3.52) | ref. | 1.02 (0.69‐1.51) | 1.80 (0.96‐3.37) | 0.51 | 0.07 |
|
| 1.51 (0.66‐3.48) | ref. | 1.00 (0.67‐1.51) | 1.68 (0.86‐3.26) | 0.65 | 0.09 |
|
| ||||||
|
| 5 | 108 | 42 | 8 | ||
|
| 0.97 (0.39‐2.38) | ref. | 1.05 (0.73‐1.50) | 1.08 (0.53‐2.22) | 0.75 | 0.99 |
|
| 0.99 (0.40‐2.45) | ref. | 0.99 (0.68‐1.43) | 0.95 (0.45‐2.01) | 0.91 | 0.95 |
Data presented as adjusted HR and 95% CI. Models adjusted for age, sex, and smoking status at baseline (Model 1), baseline hypertension, diabetes, and dyslipidemia (Model 2).